No Picture
News

With a Two-Year Revenue Growth of 469 Percent, Cymbiotika Ranks No. 30 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies

Companies on the 2022 Inc. 5000 Regionals Pacific list had an average growth rate of 195% percent SAN DIEGO , March 15, 2022 /PRNewswire/ — Inc. Magazine today revealed that Cymbiotika is No. 30 on its third annual Inc. 5000 Regionals: Pacific list, the most prestigious ranking of the… Click here to view original post… […]

No Picture
News

Illumina prezentuje w Europie prze?omowy kompleksowy test profilowania genomowego pod k?tem nowotworów

Pojedynczy test diagnostyczny in vitro zwi?kszaj?cy mo?liwo?ci podejmowania decyzji terapeutycznych zgodnie z wytycznymi klinicznymi, umo?liwiaj?cy jednocze?nie stosowanie precyzyjnego leczenia na wczesnym etapie choroby. SAN DIEGO, 15 marca 2022 r. /PRNewswire/ — Spó?ka Illumina, Inc…. Click here to view original post… […]

No Picture
News

Illumina presenta en Europa una innovadora prueba integral de perfilado genómico para el cáncer

La única prueba de diagnóstico in vitro ayuda a documentar las decisiones de terapia de acuerdo con las pautas clínicas para permitir la medicina de precisión antes en el proceso de la enfermedad. SAN DIEGO, 15 de marzo de 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN) anunció hoy el… Click here to view original post… […]

No Picture
News

Wugen Announces First Patient Dosed in Phase 1/2 Trial of WU-CART-007 for the Treatment of Patients with R/R T-ALL/LBL

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that the first patient has been dosed in a Phase 1/2 trial of WU-CART-007 for the treatment of relapsed… Click here to view original post… […]

No Picture
News

Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications

SAN DIEGO–(BUSINESS WIRE)– #3Dgenomics–Arima Genomics closes $7M series B financing to support continued growth of 3D genomics portfolio for research and translational applications. Click here to view original post… […]

No Picture
News

Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting

SAN DIEGO, March 15, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that it will be presenting data at the 2022 American Association… Click here to view original post… […]

No Picture
News

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey SAN DIEGO, March 15, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight™ Oncology (TSO)… Click here to view original post… […]

No Picture
News

UC San Diego Awarded $38 Million USAID Grant to Improve Global Health Equity

The U.S. Agency for International Development has funded a $38 million, five-year project led by UC San Diego researchers to better understand and promote health agency for individuals, communities and local organizations in low- and middle-income countries. Click here to view original post… […]

No Picture
News

Financial Incentives Can Reduce Vaccine Hesitancy, but only in Large Amounts

Financial incentives and other nudges have been used to help increase vaccination rates across the nation, but new research from the University of California San Diego’s Rady School of Management reveals that compensations need to be large—at least $100—to reduce vaccine hesitancy. Click here to view original post… […]

No Picture
News

Breg Announces New President and CEO

Orthopedic Company Recruits Global Medical Technology Leader to Advance Next Phase of Expansion CARLSBAD, Calif., March 14, 2022 /PRNewswire/ — Breg, Inc., a leading orthopedic bracing and billing services company, announced today that its board of directors has appointed Kevin Hobert… Click here to view original post… […]

No Picture
News

Researchers ID Sex Pheromone of Invasive Giant Hornet

UC San Diego scientists have developed a method for tracking the invasive Asian giant “murder” hornet’s presence and possibly accelerate its removal. The researchers identified the Asian giant hornet queen’s sex pheromone, an achievement that could be used as bait to trap and track the insects…. Click here to view original post… […]

No Picture
News

CliniComp Expands Data Acquisition Offering by Deploying Wireless Capability at Veterans Affairs Heart of Texas Health Care Network

SAN DIEGO, March 14, 2022 /PRNewswire/ — CliniComp introduces and announces the installation of its wireless data acquisition system, nDAS, for the Veterans Integrated Service Network (VISN) 17, VA Heart of Texas Health Care Network. The nDAS installation expands current data acquisition… Click here to view original post… […]

No Picture
News

Illumina Welcomes Carissa Rollins as Chief Information Officer

SAN DIEGO, March 14, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that Carissa Rollins will join the company as Chief Information Officer on March 14, 2022. Rollins brings over 30 years of business technology transformation and digital and consumerization strategy… Click here to view original post… […]

No Picture
News

Melax Tech Receives NIH Award to Construct AI-assisted Application Using COVID-19 Data Sets

HOUSTON, March 14, 2022 /PRNewswire/ — Melax Tech, along with the San Diego Supercomputer Center at UC San Diego, announces the securing of a Phase I NIH SBIR contract focused on the development and enhancement of innovative user-focused informatic tools for use in basic and clinical… Click here to view original post… […]

No Picture
News

RG6501 (OpRegen®) Full Phase 1/2a Results to Be Featured at 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Allen C. Ho, M.D., FACS

CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that full results from a Phase 1/2a clinical study of RG6501 (OpRegen®), a retinal pigment epithelium cell transplant therapy currently in development for the treatment… Click here to view original post… […]

No Picture
News

FIT4MOM ANNOUNCES FORMATION OF EXPERT ADVISORY BOARD

SAN DIEGO, March 14, 2022 /PRNewswire/ — FIT4MOM, the nation’s leading fitness company for moms, announces its newly formed expert Advisory Board of trusted leaders. This diverse Board will bring their comprehensive expertise to provide guidance, advice, and resources to FIT4MOM as well… Click here to view original post… […]

No Picture
News

Paper Reporting Results from Helixmith’s Phase 3 Gene Therapy Trial for Painful Diabetic Neuropathy was One of the Top-10 Most-Downloaded Articles in Clinical and Translational Science

SAN DIEGO, March 14, 2022 /PRNewswire/ — Helixmith announced today that their publication, "Gene therapy for diabetic neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor," was one of the top-10 most-downloaded… Click here to view original post… […]

No Picture
News

Seqster Launches Developer Portal Delivering Longitudinal Health Data and Patient Engagement Directly Into Life Science Enterprise Workflows

Seamlessly integrate workflows with Seqster’s new Web SDK, Mobile SDK and FHIR API on the HIPAA and FDA compliant Operating System SAN DIEGO, March 14, 2022 /PRNewswire/ — Seqster PDM, Inc. ("Seqster"), the leading patient-centric healthcare technology company, announced today at HIMSS… Click here to view original post… […]

No Picture
News

Salk scientists receive 2022 Mark Foundation Endeavor Award to study lung cancer

LA JOLLA—Professors Reuben Shaw, Susan Kaech, Christian Metallo and Alan Saghatelian have received a 2022 Mark Foundation for Cancer Research Endeavor Award to support their research exploring the metabolic changes that help lung cancers develop. The $3 million Endeavor Award promotes collaborative science to tackle some… Click here to view original post… […]

No Picture
News

California stem cell clinic to pay out $3.65M settlement to former patients for ineffective treatments

Four years after the FDA admonished stem cell clinic StemGenex for making dubious claims about its services in treating incurable diseases, and 3 years after the company first filed for bankruptcy, the clinic and its former CMO seem to have reached their final destination: a $3.65 million bill in a… Click here to view original post… […]

No Picture
News

Centessa gives Antoine Yver a new role, brings his old colleague on board; Prelude to a change: Jane Huang sets up her next move

Antoine Yver ? Centessa looked to Daiichi Sankyo to fill the CMO post with Antoine Yver back in May 2021, and now that Yver has garnered a new title, why mess with a good thing? Yver has been installed as chairman… Click here to view original post… […]

No Picture
News

Acadia Pharmaceuticals to Present at the 1st Annual Needham Virtual Neuroscience Forum on March 16, 2022

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 1st Annual Needham Virtual Neuroscience Forum on Wednesday, March 16, 2022 at 3:20 p.m. Eastern Time. A live webcast of Acadia’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and… Click here to view original post… […]

No Picture
News

Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021

SAN DIEGO, March 10, 2022 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced updates and… Click here to view original post… […]

No Picture
News

Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates

SAN DIEGO, March 10, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced its financial results for the fourth quarter… Click here to view original post… […]

No Picture
News

CYMBIOTIKA EXPANDS PRODUCT OFFERINGS IN AUSTRALIAN MARKET

SAN DIEGO, March 10, 2022 /PRNewswire/ — Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically-backed supplements, today announced the release of eight new products available on its Australian website. Following the official market launch and… Click here to view original post… […]

No Picture
News

9am.health Offers Affordable, Convenient, At-Home Laboratory Testing Through BioReference Laboratories

SAN DIEGO, March 10, 2022 /PRNewswire/ — 9am.health, a new virtual diabetes clinic, is proud to announce its collaboration with BioReference Laboratories, Inc., an OPKO Health company, to offer their patients the ability to get blood drawn for diagnostic laboratory tests from the… Click here to view original post… […]

No Picture
News

Regen BioPharma, Inc. Announces Program to Fast-Track its Checkpoint Inhibitor Program Utilizing Modified mRNA and siRNA Technologies

SAN DIEGO, March 10, 2022 /PRNewswire/ — Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced a program to accelerate the clinical development of its NR2F6 therapies. The Company intends to combine modified mRNA technology with Regen’s existing siRNA ( small interfering… Click here to view original post… […]